A noticeable increase in the incidence of venous obstructive disorders, driven by lifestyle factors, sedentary habits, and obesity, impacts global health significantly. The global geriatric population is surging, leading to a higher prevalence of age-related venous issues.

WILMINGTON, Del., July 17, 2024 /PRNewswire/ -- The global venous stents market stood at US$ 1.1 billion in 2023, and the global market is projected to reach US$ 2.4 billion in 2034. The venous stents market is anticipated to expand at a CAGR of 7.2% between 2024 and 2034.

The venous stents market is experiencing significant growth, driven by a combination of increasing incidence of venous obstructive disorders and a surging global geriatric population. Venous stents, crucial for treating conditions such as deep vein thrombosis (DVT) and chronic venous insufficiency, are seeing heightened demand as these conditions become more prevalent.

Lifestyle changes, including increased sedentary behavior and rising obesity rates, contribute to the growing number of venous disorders. Consequently, the need for effective treatment options, including venous stents, has surged.

Advancements in medical technology are also propelling the venous stents market forward. Innovations in stent design and materials have led to the development of more efficient, durable, and biocompatible stents, enhancing patient outcomes and expanding the potential applications of these devices.

Request a PDF Sample of this Report Now!

https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=34877 

Additionally, minimally invasive procedures associated with venous stent placement are increasingly preferred over traditional surgical methods due to their reduced recovery times and lower complication rates, further driving market growth.

The aging global population is another significant factor influencing the market. As the number of elderly individuals rises, so does the prevalence of age-related venous conditions. Older adults are more susceptible to venous insufficiency and other circulatory issues, increasing the demand for venous stenting procedures.

This demographic shift is particularly pronounced in developed regions, but developing countries are also witnessing similar trends as healthcare infrastructure improves and life expectancy increases.

Geographically, North America dominates the venous stents market due to advanced healthcare systems, higher healthcare expenditure, and a substantial patient pool.

The venous stents market is poised for robust growth, supported by technological advancements, demographic shifts, and increasing awareness about venous health. As healthcare providers continue to adopt and refine venous stenting procedures, the market is expected to expand further, meeting the rising demand for effective venous disorder treatments.

Unlock Growth Potential in Your Industry! Download PDF Brochure: https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=34877

Advancements in stent technologies, such as the development of bio absorbable and drug-eluting stents, are propelling market growth by improving patient outcomes and reducing complications. The venous stents market is also driven by an increasing prevalence of chronic venous diseases and a growing aging population, which is more susceptible to venous insufficiencies.

Market trends include the rising adoption of minimally invasive procedures, increased focus on personalized medicine, and a surge in clinical trials aimed at enhancing stent efficacy and safety.  Furthermore, collaborations between healthcare providers and medical device companies to develop innovative treatment solutions are on the rise. It is anticipated that the venous stents market would keep expanding in the future. The market for cutting-edge stent technology will be propelled by rising healthcare costs as well as increased knowledge of venous disorders and associated treatments. Moreover, continued research and development initiatives will result from the emphasis on enhancing the quality of life for those with venous illnesses. Better patient outcomes and more treatment alternatives will be made available to the market as new goods and technology are developed.

 As new products and technologies are introduced, the market will benefit from enhanced treatment options and better patient outcomes. Thus, increasing launches of technologically advanced venous stent system which is expected to boost the market growth. for instance, On June 2024, Koninklijke Philips N.V., launched Duo Venous Stent System for treatment of symptomatic venous outflow obstruction

Key Takeaways of Market Report

• Global venous stents market to generate absolute dollar opportunity worth US$ 2.4 billion until 2034.
• Global venous stents market is valued at US$ 1.1 billion in 2023.
• North America is forecasted to hold the largest share in 2023.

Venous Stents Market: Growth Drivers

• Multiple studies indicate a high prevalence of chronic venous insufficiency across various population groups, with deep vein thrombosis (DVT) being a significant obstructive disorder affecting the lower limb venous system. This condition impairs the venous reflex mechanism, necessitating effective treatments.
• Venous stenting has advanced significantly with the development of dedicated venous stents and sophisticated thrombectomy devices. The approval of several new venous stenting devices by regulatory authorities has notably boosted the market value. These innovations have enhanced treatment efficacy, driving demand and expanding the venous stents market.

Venous Stents Market: Regional Landscape

• North America held a dominant share of the venous stents market, driven by advanced healthcare infrastructure, significant investments in research, and substantial healthcare funding. These factors collectively enhance market dynamics and innovation in the region.
• The Asia Pacific region is experiencing the highest CAGR in the venous stents market, primarily due to a steep rise in the geriatric population in countries like Japan and China. Although the prevalence of venous diseases is relatively lower than in the West, the increasing elderly population fuels the demand for venous stents to treat venous obstructive disorders.

Venous Stents Market Report Scope:

Venous Stents Market: Key Players

• In 2023, Bentley InnoMed GmbH introduced an advanced venous stent system designed to enhance flexibility and durability, addressing specific challenges in treating complex venous obstructions. This development emphasizes improved patient outcomes and procedural success, reinforcing Bentley InnoMed's commitment to innovation in the venous stents market.
• In 2023, Boston Scientific Corporation launched a next-generation venous stent featuring cutting-edge design and material technology for superior performance in the treatment of deep vein thrombosis (DVT) and chronic venous insufficiency. This stent offers enhanced deliverability and conformability, reflecting Boston Scientific's ongoing efforts to expand its portfolio and improve treatment options for venous obstructive disorders.

Venous Stents Market: Segmentation

Technology

• Iliac Vein Stent Technology
• Wallstent Technology
• Others

Material

• Nitinol
• Elgiloy
• Stainless Steel

Stent Design

• Braided
• Laser-cut
• Open-cell
• Closed-cell

Placement of Stent

• Lower Limbs
• Thorax
• Abdomen
• Upper Limbs

Indication

• Chronic Deep Vein Thrombosis
• Post Thrombotic Syndrome
• May-Thurner Syndrome
• Nutcracker Syndrome
• Hemodialysis / Arteriovenous Fistulae
• Others

End User

• Hospitals
• Ambulatory Surgical Centers
• Specialty Centers
• Others

Region

• North America
• Europe
• Asia Pacific
• Middle East & Africa
• Latin America

Buy this Premium Research Report: https://www.transparencymarketresearch.com/checkout.php?rep_id=34877&ltype=S 

More Trending Reports by Transparency Market Research –

• Coronary Stents Market - The global coronary stents market is projected to advance at a CAGR of 12.9% from 202 to 2028
• Biliary Stents Market - The global biliary stents market is projected to expand at a CAGR of 5.2% during the forecast period from 2023 to 2031
• Cartilage Degeneration Market - Cartilage Degeneration Market to grow at a CAGR of 7.1% from 2024 to 2034 and reach US$ 24.9 Bn by the end of 2034

About Transparency Market Research

Transparency Market Research, a global market research company registered at Wilmington, Delaware, United States, provides custom research and consulting services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insights for thousands of decision makers. Our experienced team of Analysts, Researchers, and Consultants use proprietary data sources and various tools & techniques to gather and analyses information.

Our data repository is continuously updated and revised by a team of research experts, so that it always reflects the latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in developing distinctive data sets and research material for business reports.

Contact:
Transparency Market Research Inc.
CORPORATE HEADQUARTER DOWNTOWN,
1000 N. West Street,
Suite 1200, Wilmington, Delaware 19801 USA
Tel: +1-518-618-1030
USA – Canada Toll Free: 866-552-3453
Website: https://www.transparencymarketresearch.com   
Email: sales@transparencymarketresearch.com
Follow Us: LinkedIn| Twitter| Blog | YouTube

Logo: https://mma.prnewswire.com/media/1682871/TMR_Logo_Logo.jpg

View original content:https://www.prnewswire.com/news-releases/surge-in-prevalence-of-venous-disorders-drives-venous-stents-market-to-reach-us-2-4-billion-by-2034--growing-at-7-2-cagr-transparency-market-research-302199358.html

SOURCE Transparency Market Research